Retiring in 2022? Ask Yourself These 3 Questions First
Are you actually ready to retire? Here’s how to find out.
If You Own This Stock, It’s Time to Buy More
This retail giant is a pandemic and post-pandemic winner.
3 Unstoppable Stocks to Buy No Matter What Happens in 2022
These stocks are poised for long-term success regardless of how this year unfolds.
Want $7,000 in Annual Income? Invest $100,000 in These 3 Dividend Stocks
These stocks give income investors a lot of bang for the buck.
February 4, 2022 — In The Know with Cathie Wood
On episode XXV of In the Know, ARK CEO/CIO, Cathie Wood, weighs in on inflation, interest rates, oil prices, retail sales, crypto, and more…
Strobe light for 5G: Imaging system spotlights the tiny mechanical hearts at the core of every cellphone
Researchers have developed an instrument to image the acoustic waves generated by micromechanical resonators over a wide range of frequencies and produce ‘movies’ of them with unprecedented detail.
Preventing pandemics costs far less than controlling them
An analysis by epidemiologists, economists, ecologists and biologists at 21 institutions finds we could reduce the risks of future pandemics by investing as little as 1/20th of the losses incurred so far from COVID into conservation measures designed t…
The abyssal world: Last terra incognita of the Earth surface
The first unified vision of the world ocean biodiversity, based on analysis of DNA sequences from the surface to deep-ocean sediments, unveils the rich and unknown life in the abyssal realm, the last terra incognita of the Earth surface. This collectiv…
Discovery unravels how atomic vibrations emerge in nanomaterials
A hundred years of physics tells us that collective atomic vibrations, called phonons, can behave like particles or waves. When they hit an interface between two materials, they can bounce off like a tennis ball. If the materials are thin and repeating…
RNA ‘heroes’ can disarm bad-actor proteins in leukemia
Scientists believe it may be possible to prevent DNA changes driven by two proteins highly active in leukemia and other cancers. They recently reported a new mechanistic target for drug development.
Making metal–halide perovskites useful in planar devices through a new hybrid structure
Two of the main drawbacks of using tin (Sn)-based metal halide perovskites (MHPs) in thin-film transistors have been simultaneously solved by an innovative hybrid 2D/3D structure. New findings will help unlock the potential of environmentally benign Sn…
Too many disk galaxies than theory allows
The Standard Model of Cosmology describes how the universe came into being according to the view of most physicists. Researchers have now studied the evolution of galaxies within this model, finding considerable discrepancies with actual observations.
Too many disk galaxies than theory allows
The Standard Model of Cosmology describes how the universe came into being according to the view of most physicists. Researchers have now studied the evolution of galaxies within this model, finding considerable discrepancies with actual observations.
Widely-used hormone drug associated with increased risk of benign brain tumor at high doses
High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma — the most common type of benign brain tumor, finds a new study …
How our body controls inflammation during clean-up mechanisms of damaged cells
A research team has investigated in detail how messenger substances signal inflammation during the removal of damaged cells in the body. Using high-resolution microscopy methods, the researchers were able to show that two proteins interact dynamically …
Researchers resurrect and improve a technique for detecting transistor defects
Researchers have revived and improved a once-reliable technique to identify and count defects in transistors, the building blocks of modern electronic devices such as smartphones and computers.
Those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies, study finds
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs) — a highly effective treatment for the disease — both across and within U.S. states, according to new research.
US household air conditioning use could exceed electric capacity in next decade due to climate change
An 8% increase in summer air conditioning demand can be expected in the U.S. when the global average temperature exceeds 1.5 degrees Celsius above pre-industrial levels. This climate driven increase is likely to cause prolonged blackouts during peak su…
Study looks at glacial lakes, dams in Alaska and potential for flooding
Researchers have produced a detailed inventory of glacial lakes and dams over a 35-year timeframe from 1984 to 2019 in Alaska and northwest Canada.
Dose-finding trial paves way for new rotavirus vaccine to prevent a deadly diarrheal disease from birth
Researchers have found a reduced dose of an Australian-developed rotavirus vaccine produced a robust immune response in children at risk from deadly diarrheal disease in Africa.